Percutaneous Coronary Intervention.
complex PCI, intravascular imaging & rotational atherectomy
Dr Matias Yudi has trained extensively in all aspects of coronary artery interventions. During his time at Mt Sinai Medical Centre in New York, a centre world-renowned for tackling the toughest cases, he gained significant experience in managing complex patients with advanced coronary artery disease.
coronary interventions provided:
Coronary Angiography and Percutaneous Coronary Intervention (PCI)
Complex PCI (Left Main, Bifurcation, Chronic Total Occlusion)
Rotational Atherectomy
Intravascular Imaging (IVUS, OCT)
Haemodynamic Assessment (FFR)
Transcatheter Aortic Valve Implantation (TAVI).
minimally invasive alternative to surgical aortic valve replacement
Trans-catheter Aortic Valve Replacement is a minimally invasive procedure indicated in patients with a narrowed heart valve, otherwise known as ‘Aortic Stenosis’. This narrowing makes it difficult for the aortic valve to open properly, forcing the heart to work harder to pump blood to the body and may result in breathlessness, chest pain, fatigue and fainting spells.
TAVI has revolutionised the management of Aortic Stenosis in patients who would otherwise be at high risk during open heart surgery. The procedure is performed through the major vessel in the leg and does not require an operation. In contrast to open heart surgery, patients usually only need 3 to 4 days in hospital to recover from the procedure.
Left Atrial Appendage Closure.
a structural alternative to anticoagulation for patients with af
The Left Atrial Appendage Closure Device offers an alternative to blood thinning medications for patients with atrial fibrillation.
The Left Atrial Appendage is a small pouch, shaped like a windsock, in the top chamber of the heart. When the heart is in an irregular rhythm, called Atrial Fibrillation (AF), blood clots can form in this appendage and can travel to the brain causing a stroke. This device is a permanent heart implant which is placed in the left atrial appendage. This effectively reduces the risk of stroke, without the risk of bleeding which comes from the long term use of blood thinning medications.
This is a minimally invasive procedure. The heart is accessed via the vessels in the leg and patients will need to stay in hospital for 1 night. Most patients will be able to stop taking blood thinning medications 45 days after the procedure.
Patent Foramen Ovale Closure.
to reduce recurrent events in patients with cryptogenic stroke
The Foramen Ovale is an opening between the two upper chambers of the heart which is present before birth and allows for circulation of blood. After birth, this communication closes in most people to form a solid wall. If it does not close it is called a Patent Foramen Ovale (PFO). A PFO can allow blood to pass unfiltered, from the right atrium to the left atrium and out into the body, including the brain and may be associated with an increased risk of stroke.
A PFO is typically closed with a minimally invasive procedure. The heart is accessed via the vessels in the leg and patients are usually able to go home on the day of the procedure.
Atrial Septal Defect Closure.
closure device for haemodynamically significant septal defects
An Atrial Septal Defect is an opening in the wall that separates the top chambers of the heart. This can be repaired with a small device that closes the communication between the left and right atrium. It is a minimally invasive procedure. The heart is accessed via the vessels in the leg and patients are usually admitted to hospital for 1 night.
Transcatheter Mitral Valve Repair.
‘mitraclip’
Trans-catheter Mitral Valve Repair is a minimally invasive technique for treatment of selected patients with symptomatic, severe mitral regurgitation. Mitral regurgitation can be caused by a primary disease of the valve leaflets or by secondary (functional) causes such as left ventricular remodeling from heart failure or coronary artery disease.
Trans-catheter Mitral Valve Replacement has recently emerged as an exciting new frontier in the field of cardiac structural intervention and is an alternative to mitral valve surgery in selected patients. It is a minimally invasive procedure. The heart is accessed through the vessels in the legs and patients typically spend 1-2 nights in hospital.
Percutaneous Mitral Balloon Valvuloplasty.
for management of severe rheumatic mitral stenosis
Percutaneous Balloon Mitral Valvuloplasty is a procedure used to dilate the mitral valve in the setting of rheumatic mitral valve stenosis. It is a minimally invasive procedure where a balloon traverses the narrowed valve and is inflated to relieve the obstruction. The heart is accessed through the vessels in the legs and patients are usually admitted to hospital for 1 night.